Cipla Ltd vs Gennex Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Cipla Ltd is ₹ 1388 as of 12 Jun 15:30 . The P/E Ratio of Cipla Ltd changed from 27.3 on March 2021 to 25.5 on March 2026 . This represents a CAGR of -1.13% over 6 yearsThe P/E Ratio of Gennex Laboratories Ltd changed from 12.2 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Cipla Ltd changed from ₹ 65746 crore on March 2021 to ₹ 98795 crore on March 2026 . This represents a CAGR of 7.02% over 6 yearsThe Market Cap of Gennex Laboratories Ltd changed from ₹ 49.46 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Cipla Ltd for the Mar '26 is ₹ 6689 crore as compare to the Dec '25 revenue of ₹ 7280 crore. This represent the decline of -8.12% The revenue of Gennex Laboratories Ltd for the Mar '26 is ₹ 62.27 crore as compare to the Dec '25 revenue of ₹ 42.96 crore. This represent the growth of 44.95% The ebitda of Cipla Ltd for the Mar '26 is ₹ 1103 crore as compare to the Dec '25 ebitda of ₹ 1185 crore. This represent the decline of -6.95% The ebitda of Gennex Laboratories Ltd for the Mar '26 is ₹ 6.9 crore as compare to the Dec '25 ebitda of ₹ 8.27 crore. This represent the decline of -16.57% The net profit of Cipla Ltd changed from ₹ 1176 crore to ₹ 550.11 crore over 8 quarters. This represents a CAGR of -31.61% The net profit of Gennex Laboratories Ltd changed from ₹ 4.66 crore to ₹ 4.46 crore over 8 quarters. This represents a CAGR of -2.17% The Dividend Payout of Cipla Ltd changed from 16.34 % on March 2021 to 29.87 % on March 2026 . This represents a CAGR of 10.58% over 6 yearsThe Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Cipla Ltd

Cipla Limited is one of the leading pharmaceutical companies in India.
The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'.

About Gennex Laboratories Ltd

Gennex Laboratories Limited, formerly known as Prudential Pharmaceuticals Limited was incorporated on June 25, 1985.
The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is in the business of Manufacturing of Bulk Drugs, Intermediates and Biotech Products.
The Company has over the years added more capacity and infrastructure by way of an additional production block and equipment to the plant to handle more products and tonnages.
The Company is having a professionally managed team at every stage of its operations. Apart from these, Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.

FAQs for the comparison of Cipla Ltd and Gennex Laboratories Ltd

Which company has a larger market capitalization, Cipla Ltd or Gennex Laboratories Ltd?

Market cap of Cipla Ltd is 112,193 Cr while Market cap of Gennex Laboratories Ltd is 257 Cr

What are the key factors driving the stock performance of Cipla Ltd and Gennex Laboratories Ltd?

The stock performance of Cipla Ltd and Gennex Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cipla Ltd and Gennex Laboratories Ltd?

As of June 14, 2026, the Cipla Ltd stock price is INR ₹1388.8. On the other hand, Gennex Laboratories Ltd stock price is INR ₹10.59.

How do dividend payouts of Cipla Ltd and Gennex Laboratories Ltd compare?

To compare the dividend payouts of Cipla Ltd and Gennex Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.